Amazon.com, Inc. (AMZN)
Latest news, insights and market data
Market Data
AI Insights
Amazon received an FDA warning for unapproved listings of STI treatments on its platform, which could lead to product seizures if not addressed. This regulatory issue highlights the challenges Amazon faces in managing marketplace compliance and could impact its reputation. The upcoming Q3 earnings release on October 29 will be crucial for assessing investor sentiment.
Latest News
| Title | Published |
|---|---|
CoreWeave, Oracle have an interest rate problem CoreWeave, Oracle have an interest rate problem | about 2 hours ago |
How much Amazon stock does CEO Andy Jassy actually own? How much Amazon stock does CEO Andy Jassy actually own? | about 4 hours ago |
UTES Vs. UTG: Why I Prefer The ETF As Rates Rise. UTES vs. UTG: compare total returns, rate resilience, and fees. | about 14 hours ago |
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test? Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test? | about 15 hours ago |
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test? Amazon.com, Inc. (NASDAQ:AMZN) has been flat during the last six months, as of October 15. This compares to a 21.5% return for the Insider Monkey Billionaire Index and 15.74% for the State Street SPDR S&P 500 ETF Trust. Amazon has a history of building businesses that eventually become valuable in their own right. AWS started […] | about 15 hours ago |
2 Retail Stocks to Buy Before the Holiday Shopping Season Black Friday is around six weeks away. Which two retailers look worth owning before the rush? | about 19 hours ago |
3 Cash Flow Stocks To Watch In October 2026 3 Cash Flow Stocks To Watch In October 2026 | about 19 hours ago |
CoreWeave, Oracle have an interest rate problem
CoreWeave, Oracle have an interest rate problem
How much Amazon stock does CEO Andy Jassy actually own?
How much Amazon stock does CEO Andy Jassy actually own?
UTES Vs. UTG: Why I Prefer The ETF As Rates Rise.
UTES vs. UTG: compare total returns, rate resilience, and fees.
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test?
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test?
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test?
Amazon.com, Inc. (NASDAQ:AMZN) has been flat during the last six months, as of October 15. This compares to a 21.5% return for the Insider Monkey Billionaire Index and 15.74% for the State Street SPDR S&P 500 ETF Trust. Amazon has a history of building businesses that eventually become valuable in their own right. AWS started […]
2 Retail Stocks to Buy Before the Holiday Shopping Season
Black Friday is around six weeks away. Which two retailers look worth owning before the rush?
3 Cash Flow Stocks To Watch In October 2026
3 Cash Flow Stocks To Watch In October 2026